anti-CD56-CAR-T / Affiliated Hospital of Xuzhou Medical University - LARVOL DELTA

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia (clinicaltrials.gov) - P2 | N=20 | Recruiting | Sponsor: The Affiliated Hospital of Xuzhou Medical University

New P2 trial • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • T Cell Non-Hodgkin Lymphoma • IL10 • IL4 • IL6 • NCAM1